What is the difference between relapsing-remitting and progressive MS?

RRMS shows itself in attacks with recovery and stable periods between them. Progressive MS worsens steadily, either from the start (primary progressive) or after a relapsing phase (secondary progressive). Some people have features of both. The distinction matters because relapse-driven inflammation responds well to today's therapies, while slow progression is harder to treat.

Does relapsing-remitting MS always turn into secondary progressive MS?

No. Before disease-modifying therapy, most people with RRMS eventually transitioned, but that was in an era with no treatment. With sustained control of relapses and MRI activity, many people remain in a stable relapsing course for decades, and the proportion who transition appears to be falling.

What is the life expectancy with RRMS?

Life expectancy with RRMS is close to that of the general population, and the gap has narrowed with modern treatment. Most people with RRMS live into older age. Looking after the rest of your health, including blood pressure, blood sugar, and not smoking, matters as much with MS as it does for anyone.

Can you have relapsing-remitting MS with no symptoms?

Yes. Between relapses, many people feel entirely well while MRI shows continuing activity. That is why therapy is not stopped when symptoms are quiet and why monitoring scans are scheduled even when nothing seems to be happening.

How often do relapses happen?

Untreated, roughly one relapse every one to two years on average early in the disease, with wide variation. On an effective therapy, many people go years without one. A relapse on treatment is a reason to review the therapy, not simply to treat the relapse and carry on.

What is highly active relapsing-remitting MS?

It is RRMS with more inflammation than usual: frequent or disabling relapses with new lesions on MRI, or relapses and new lesions that continue despite treatment. There is no single agreed definition. The label usually leads to a high-efficacy therapy early, and it is a reason for review by an MS specialist, not a prediction of how your life will go.

What is the first-line treatment for RRMS?

There is no single first-line therapy for everyone. The term comes from escalation, the older approach of starting with a moderate-efficacy therapy and stepping up only if the disease broke through. Many MS specialists now offer a high-efficacy therapy, such as a B-cell therapy, as the first treatment, especially when MS is active. Which therapy suits you is a decision you make together with your neurologist.

Is relapsing-remitting MS considered a disability?

MS can qualify as a disability depending on how it affects your work and daily function, which varies enormously between people. Many people with RRMS work full time for decades. If you need documentation for work accommodations, we can provide it.

Relapsing-Remitting MS (RRMS): Does It Get Worse Over Time?

What relapsing-remitting MS is

Multiple sclerosis is classified by how it behaves over time, not by how severe it is. Relapsing-remitting MS, usually shortened to RRMS, is the course in which the disease shows itself as separate episodes. A new symptom appears, builds over hours to days, stays for a few weeks, and then improves. Recovery can be complete, or it can leave something behind. Then there is a quiet period until the next relapse, and on an effective therapy that quiet period often lasts years.

The word "remitting" describes the symptoms, not the disease. Between relapses, MRI often shows new or enlarging lesions that never produced a symptom, because they landed in a part of the brain that does not announce itself. Roughly ten silent lesions form for every relapse a person notices. That gap between what you feel and what the scan shows is the single most important idea in RRMS, because it is the reason treatment is continued when you feel entirely well. Our MRI guide explains what new lesions on a monitoring MRI mean for your treatment.

A single line rising into a peak, settling, rising again, and settling, with a small brain silhouette at its start. — Symptoms rise during a relapse and settle afterwards, with stable periods in between.

RRMS symptoms: what a relapse feels like

A relapse is defined by its timing as much as by the symptom. It comes on over hours to a few days, lasts at least 24 hours, and happens without a fever or infection that could explain it. The early signs of MS and the symptoms of a later relapse are drawn from the same list, because both come from a new area of inflammation somewhere in the brain, spinal cord, or optic nerve:

Vision. Blurred or dim vision in one eye with pain on eye movement (optic neuritis), or double vision.
Sensation. Numbness or tingling in a limb, one side of the face, or a band around the trunk.
Strength and balance. Weakness in a leg or arm, stiffness, unsteadiness, or vertigo.
Bladder. New urgency, frequency, or trouble emptying.
Lhermitte's sign. A brief electric sensation down the spine when the neck bends forward.

Between relapses, many people still live with symptoms that run in the background rather than arriving as an attack. Fatigue is common and often out of proportion to what you have done. Many people are sensitive to heat: a hot day, a hot shower, or a fever can make old symptoms louder for a few hours. Thinking can feel slower, with brain fog on demanding days, and mood changes are common too. These symptoms are real and treatable, and they are worth raising at every visit, even when the MRI is quiet.

Is it a new relapse or an old symptom flaring?

Old symptoms that return when you are overheated, ill, or exhausted are usually a pseudo-relapse, a damaged pathway working worse under strain, and they settle once the trigger passes. Our relapse guide's two-question test for a true relapse helps you tell the two apart and decide when to call.

Does relapsing-remitting MS get worse?

It can, in two ways, and treatment changes the odds of both.

The first is incomplete recovery. Each relapse carries a chance of leaving a residual deficit, and those add up. Effective disease-modifying therapy cuts the number of relapses substantially, so there are fewer chances for that to happen.

The second is a change in the course itself. Historically, many people with untreated RRMS moved, after ten to twenty years, into secondary progressive MS, where disability accumulates steadily without clear relapses. Research over the last decade has shown that some of this slow worsening happens even in the relapsing phase, independent of relapses, a pattern now called progression independent of relapse activity. That finding is one of the reasons the field has moved toward starting a highly effective therapy early rather than escalating later. In the modern treatment era, long-term studies show far fewer people reaching the milestones of disability that were once expected.

None of this is a schedule. Two people with RRMS diagnosed the same year can have very different decades ahead of them, and the largest controllable variable is how well the disease is controlled from the start.

Highly active RRMS

Hearing that your MS is "highly active" is frightening, but the label says more about treatment than about your future. There is no single agreed definition. It usually means one of two things: frequent or disabling relapses with new lesions on MRI, or MS that keeps relapsing or forming new lesions despite treatment.

Highly active disease is the clearest case for starting a high-efficacy therapy, or switching to one promptly, usually one of the B-cell therapies (ocrelizumab, ofatumumab, or ublituximab) or natalizumab. When inflammation is this active, waiting to see whether a milder therapy works costs time the nervous system cannot always get back.

The label is a reason for a specialist review, not a verdict. An MS specialist will look at the actual scans and the relapse history, make sure the activity really is MS rather than a condition that mimics it, and set out the options with their monitoring and risks. The goal is the same as for anyone with RRMS: no new relapses, no new lesions, and no worsening.

How long does relapsing-remitting MS last?

RRMS is lifelong: it does not burn out or go away. What people usually mean by the question is how long the relapsing phase lasts before it changes character, and the honest answer is that it varies widely and is shifting with treatment. Before disease-modifying therapy, the relapsing phase typically lasted one to two decades. With sustained control of relapses and MRI activity, many people stay in a stable relapsing course for much longer, and some never show a clear transition at all. Life expectancy in MS is close to that of the general population, and the gap has narrowed with treatment.

Relapsing-remitting or progressive?

Relapsing MS can become progressive: that shift is what secondary progressive MS means, and some people have features of both for a while. The two courses differ in three practical ways.

	Relapsing-remitting MS	Progressive MS
How it shows itself	Attacks that build over days and then improve, with stable stretches in between	Slow, steady worsening over at least a year, most often in walking
What the MRI shows	New or enlarging lesions, some lighting up with contrast while inflammation is active	Fewer new lesions; more gradual damage, such as loss of brain volume and spinal cord injury
How treatment works	Every approved disease-modifying therapy targets relapses and new lesions, so the choice is wide	Fewer options: ocrelizumab for primary progressive MS, siponimod and the relapsing-form therapies for active secondary progressive MS, plus rehabilitation

Our page on primary versus secondary progressive MS explains the two progressive forms and what treatment can do for each.

How RRMS is diagnosed

The diagnosis of MS itself rests on the history, the examination, MRI of the brain and spine, and sometimes spinal fluid, applied through the McDonald criteria. Whether the course is relapsing-remitting or progressive is a clinical judgment about how symptoms have behaved over time, which is why the first visit spends so long on the timeline. A full MS evaluation also rules out the conditions that mimic MS on a scan, and checks that a first episode is not a clinically isolated syndrome that does not yet meet criteria.

Treatment

Every approved disease-modifying therapy for MS is approved for relapsing forms, so RRMS has the widest range of options: self-injections, daily pills, and infusions given every few months. They differ substantially in how much they reduce relapses and new lesions, in their safety monitoring, and in how they fit with pregnancy plans, other conditions, and daily life. Our treatment guide compares the classes, and the B-cell therapy comparison covers the most used high-efficacy options.

You may hear a therapy called "first-line". The term comes from an approach called escalation: start with a moderate-efficacy therapy, such as interferon beta or glatiramer acetate, and step up to a stronger one only if relapses or new lesions break through. Many MS specialists now start with a high-efficacy therapy instead, for the reasons described above: damage from early inflammation, including the silent kind, does not always fully recover. Neither approach is right for everyone. The choice is a shared decision that weighs how active your MS is, your other health conditions, pregnancy plans, and how you feel about each therapy's monitoring and risks.

The approach in this practice is to start an effective therapy early, monitor with MRI and blood work on a schedule, and change therapy rather than tolerate a disease that is still active on it. A relapse or a new lesion on a therapy is information, not a failure on your part.

A pill organizer, a brain and spinal cord model, a notebook, and a cup on a wooden table. — Treatment combines a disease-modifying therapy with a monitoring plan and attention to daily symptoms.

Relapses themselves are usually treated with a short course of high-dose steroids when they are disabling, which speeds recovery but does not change the long-term course. Symptom treatment, rehabilitation, and the daily habits behind living well with MS sit alongside all of this.

When to see a neurologist

Is it a new relapse or an old symptom flaring? Call your neurologist the same day for a suspected relapse, and call 911 for sudden weakness on one side, trouble speaking, or sudden vision loss. See an MS specialist for a new diagnosis before choosing a therapy, when you are unsure your current therapy is working, and before planning a pregnancy. At our Multiple Sclerosis Clinic, Dr. Ntranos, a fellowship-trained MS specialist, reviews your MRI images with you scan by scan, in a 60-minute first visit, usually available the same or next day, in person in Beverly Hills or Los Angeles or by video anywhere in California. A relapse or a new lesion on a therapy is information, not a failure on your part. Follow-ups are usually every one to three months and last 30 to 45 minutes, and messages between visits are answered within 1 business day. Your MRI, labs, and medications continue to run through your insurance. Request a visit without a referral; the office confirms within 1 business day.

Relapsing-Remitting Multiple Sclerosis: What the Pattern Means